Amanote Research

Amanote Research

    RegisterSign In

Tivozanib in the Treatment of Renal Cell Carcinoma

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s32958
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
Date

June 1, 2013

Authors
Mehmet Hepgur
Publisher

Informa UK Limited


Related search

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Nivolumab in Treatment of Renal Cell Carcinoma During Renal Replacement Therapy

Oncology in Clinical Practice
Oncology
2019English

Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

New Systemic Approaches in the Treatment of Metastatic Renal Cell Carcinoma

2012English

Trend of Surgical Treatment of Localized Renal Cell Carcinoma

Permanente journal,The
Medicine
2019English

Nonablative Hematopoietic Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma

Bone Marrow Transplantation
TransplantationHematology
2002English

Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy